Loading...
Mobile Narcotic Treatment Programs: On the Road Again?
Breve, Frank Batastini, Lisa LeQuang, Jo Ann K. Marchando, Gina
Breve, Frank
Batastini, Lisa
LeQuang, Jo Ann K.
Marchando, Gina
Citations
Altmetric:
Genre
Journal article
Date
2022-03-16
Advisor
Committee member
Group
Department
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.7759/cureus.23221
Abstract
Many Americans with opioid use disorder (OUD), do not have access to treatment. Mobile narcotic treatment programs are now under new regulations that may make treatment more accessible to more people. These mobile programs can help expand the reach of opioid agonist treatment for OUD, help reduce human immunodeficiency viruses (HIV) and hepatitis C in the OUD population, and have retention rates that are often better than those at fixed-site clinics. Mobile services can also help reach marginalized individuals, the homeless, rural communities, and other underserved communities. They may offer methadone or buprenorphine treatment. Such mobile services have been used inside and outside the United States with promising results. In particular, mobile programs can make treatment available to people who do not have insurance, who lack reliable transportation, live in chaotic situations, or may be undomiciled. The potential pairing of mobile programs together with technology, such as smartphone apps or online resources, may allow mobile patients to benefit from counseling as well. Mobile clinics must be attached to a fixed-site narcotic treatment program and may have limitations with respect to the geographic area served. Mobile programs must have policies and procedures to store, transport, deliver, account for, reconcile, and dispose of opioid waste and would be subject to audit. Mobile opioid agonist therapy is an important and innovative service of particular value to underserved communities.
Description
Citation
Breve F, Batastini L, LeQuang J K, et al. (March 16, 2022) Mobile Narcotic Treatment Programs: On the Road Again?. Cureus 14(3): e23221. doi:10.7759/cureus.23221
Citation to related work
Springer
Has part
Cureus, Vol. 14
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu